Synopsis
Synopsis
0
JDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
Finished Drug Prices
NA
1. Cefoxitin
2. Mfoxin
3. Mefoxin
4. Mefoxitin
5. Mk 306
6. Mk-306
7. Mk306
8. Sodium, Cefoxitin
1. Cefoxitin Sodium Salt
2. 33564-30-6
3. Betacef
4. Cenomycin
5. Mefoxin
6. Merxin
7. Cefoxitin (sodium)
8. Mefoxitin
9. Mls000028557
10. Chebi:3501
11. Q68050h03t
12. Smr000058809
13. Monosodium Cefoxitin
14. Sodium (6r,7s)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate Carbamate (ester)
15. Cefoxil
16. Cefoxotin Sodium
17. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, Sodium Salt, (6r-cis)-
18. Ncgc00183034-01
19. Mk-306
20. Unii-q68050h03t
21. Prestwick_12
22. Mefoxin In Plastic Container
23. Sodium (6r,7s)-3-((carbamoyloxy)methyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
24. Sodium (6r,7s)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
25. Einecs 251-574-6
26. Mefoxin (tn)
27. Cas-33564-30-6
28. Mfcd00079042
29. Mk 206
30. Cefoxitin Na
31. Cefoxitin Sodium [usan:usp:ban:jan]
32. Cefoxitin And Dextrose In Duplex Container
33. Opera_id_912
34. Cefoxitin (sodium Salt)
35. Sodium;(6r,7s)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
36. Dsstox_cid_28921
37. Dsstox_rid_83187
38. Dsstox_gsid_48995
39. Schembl41178
40. Cefoxitin Sodium (jan/usp)
41. Mefoxin In Dextrose 5% In Plastic Container
42. Mls001076334
43. Mls002222151
44. Bidd:gt0505
45. Spectrum1502031
46. L 620388
47. Cefoxitin Sodium [jan]
48. Cefoxitin Sodium [usan]
49. Cefoxitin Sodium [vandf]
50. Chembl1200530
51. Dtxsid8048995
52. Cefoxitin For Peak Identification
53. Hms501m18
54. Cefoxitin Sodium [mart.]
55. Cefoxitin Sodium [who-dd]
56. Hms1570h05
57. Hms1921f14
58. Hms2092p11
59. Hms2097h05
60. Hms2232e15
61. Hms3259k10
62. Hms3714h05
63. Mefoxin In Sodium Chloride 0.9% In Plastic Container
64. Cefoxitin Sodium Salt [mi]
65. Bcp12069
66. Hy-b1117
67. Tox21_113485
68. Ccg-39693
69. Akos024464829
70. Cefoxitin Sodium [orange Book]
71. Ac-1303
72. Cefoxitin Sodium [usp Impurity]
73. Cs-4716
74. Nc00556
75. Cefoxitin Sodium [usp Monograph]
76. As-56725
77. Sodium (6r-cis)-3-((carbamoyloxy)methyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
78. C3602
79. C-2480
80. C08106
81. D00913
82. A821839
83. (r)-4-isopropyl-5,5-diphenyl-2-oxazolidinone
84. Q27106110
85. Cefoxitin Sodium Salt, Antibiotic For Culture Media Use Only
86. (6r,7s)-3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[420]oct-2-ene-2-carboxylic Acid Sodium Salt
87. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, Monosodium Salt, (6r-cis)-
88. Sodium (6r,7s)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 449.4 g/mol |
---|---|
Molecular Formula | C16H16N3NaO7S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 8 |
Exact Mass | 449.03273649 g/mol |
Monoisotopic Mass | 449.03273649 g/mol |
Topological Polar Surface Area | 205 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Cefoxitin and dextrose in duplex container |
Active Ingredient | Cefoxitin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | B Braun |
2 of 4 | |
---|---|
Drug Name | Mefoxin in plastic container |
Active Ingredient | Cefoxitin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 40mg base/ml; eq 20mg base/ml |
Market Status | Prescription |
Company | Mylan Institutional |
3 of 4 | |
---|---|
Drug Name | Cefoxitin and dextrose in duplex container |
Active Ingredient | Cefoxitin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | B Braun |
4 of 4 | |
---|---|
Drug Name | Mefoxin in plastic container |
Active Ingredient | Cefoxitin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 40mg base/ml; eq 20mg base/ml |
Market Status | Prescription |
Company | Mylan Institutional |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18149
Submission : 2005-03-08
Status : Active
Type : II
Certificate Number : CEP 2005-108 - Rev 06
Issue Date : 2024-09-09
Type : Chemical
Substance Number : 990
Status : Valid
Date of Issue : 2019-07-22
Valid Till : 2022-07-21
Written Confirmation Number : WC-0131
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12976
Submission : 1998-04-30
Status : Active
Type : II
NDC Package Code : 52946-0828
Start Marketing Date : 2009-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20698
Submission : 2007-07-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19789
Submission : 2006-09-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21329
Submission : 2008-01-31
Status : Inactive
Type : II
Certificate Number : R0-CEP 2008-015 - Rev 01
Issue Date : 2013-06-10
Type : Chemical
Substance Number : 990
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20635
Submission : 2007-06-20
Status : Inactive
Type : II
NDC Package Code : 52946-0828
Start Marketing Date : 2009-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?